The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma

Journal of Endocrinological Investigation

Volumn 33, Issue 3, 2010, Pages 151-155

  Zhai, G ^a   Zhang, M ^a   Xu, H ^a   Zhu, C ^a   Li, B ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

18F fluorodeoxyglucose positron emission tomography computed tomography (18F FDG PET CT); Fine needle aspiration (FNA); Incidentaloma; Maximal standardized uptake value (SUVmax); Thyroid

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TRACE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; ASPIRATION BIOPSY; BENIGN TUMOR; CANCER CYTODIAGNOSIS; CANCER RISK; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MAXIMAL STANDARDIZED UPTAKE VALUE; PREVALENCE; RADIOLOGICAL PARAMETERS; RISK ASSESSMENT; THYROID INCIDENTALOMA; TUMOR VOLUME; WHOLE BODY CT; WHOLE BODY PET; COMPUTER ASSISTED TOMOGRAPHY; CYTOCHEMISTRY; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; THYROID TUMOR; WHOLE BODY IMAGING;

BIOPSY, FINE-NEEDLE; FEMALE; FLUORODEOXYGLUCOSE F18; HISTOCYTOCHEMISTRY; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREVALENCE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 77952819382     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/6499     Document Type: Article

References (19)

1. Burguera B, Gharib H. Thyroid incidentalomas: prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am 2000, 29: 187-203.
2. Lin JD, Chao TC, Huang BY, et al. Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology. Thyroid 2005, 15: 708-717 (Pubitemid 41117524)
3. Ramos CD, Chisin R, Yeung HW, et al. Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor. Clin Nucl Med 2001, 26: 193-197 (Pubitemid 32171425)
4. 18F-Fluorodeoxyglucose-positron emission tomography. Surgery 2001, 130: 941-946 (Pubitemid 34014558)
5. 18F-Fluorodeoxyglucose-positron emission tomography for me-tastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003, 88: 4100-4104
6. Ross DS. Nonpalpable thyroid nodules-managing an epidemic. J Clin Endocrinol Metab 2002, 87: 1938-1940
7. Leenhardt L, Hejblum G, Franc B, et al. Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab 1999, 84: 24-28 (Pubitemid 29036675)
8. Yasuda S, Shohtsu A, Ide M, et al. Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology 1998, 207: 775-778 (Pubitemid 28279912)
9. 18F-FDG uptake in the thyroid gland. J Nucl Med 2007, 48: 896-901. (Pubitemid 46909917)
10. 18F-Fluorodeoxyglucose-positron emission tomography for cancer screening in healthy subjects. Anticancer Res 2005, 25: 1421-1426
11. 18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results. J Nucl Med 2006, 47: 770-775
12. Yehuda M, Payne RJ, Seaberg RM, MacMillan C, Freeman JL. Fine-needle aspiration biopsy of the thyroid: atypical cytopathological features. Arch Otolaryngol Head Neck Surg 2007, 133: 477-480 (Pubitemid 46799784)
13. 18F-fluorodeoxyglucose-positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol 2005, 23: 7654-7659
14. Travis LB. The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 2006, 15: 2020-2026
15. 18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer 1999, 86: 2370-2377
16. Rheingold SR, Neugut AI, Meadows AT. Secondary cancers: Incidence, risk factors, and management. In Kufe DW, Pollock RE, Weichselbaum RR, et al. (ed): Cancer Medicine (ed 6). Hamilton, Ontario: BC Decker. 2003, 2623-2631
17. th ed. New York, NY: Springer-Verlag. 2002, 77-84.
18. 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med 2006, 47: 609-615
19. McDougall IR, Davidson J, Segall GM. Positron emission tomography of thyroid, with an emphasis on thyroid cancer. Nucl Med Commun 2001, 22: 485-492 (Pubitemid 32458175)